Clinical utility of liquid biopsy in bladder cancer: The beginning of a new era
{{output}}
Bladder cancer (BC) is the sixth most prevalent cancer in the U.S. and the most expensive to treat. Integrating precision medicine into BC management promises improved outcomes and reduced costs. This review explores current treatment paradigms and the transfo... ...
